Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Sight Sciences (SGHT) over the last 6 years, with Q3 2025 value amounting to $105000.0.

  • Sight Sciences' Depreciation & Amortization (CF) fell 3354.43% to $105000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $555000.0, marking a year-over-year decrease of 2014.39%. This contributed to the annual value of $712000.0 for FY2024, which is 1596.09% up from last year.
  • Latest data reveals that Sight Sciences reported Depreciation & Amortization (CF) of $105000.0 as of Q3 2025, which was down 3354.43% from $125000.0 recorded in Q2 2025.
  • Sight Sciences' Depreciation & Amortization (CF)'s 5-year high stood at $200000.0 during Q2 2021, with a 5-year trough of $105000.0 in Q3 2025.
  • For the 5-year period, Sight Sciences' Depreciation & Amortization (CF) averaged around $162210.5, with its median value being $159000.0 (2023).
  • In the last 5 years, Sight Sciences' Depreciation & Amortization (CF) surged by 10000.0% in 2021 and then crashed by 3354.43% in 2025.
  • Sight Sciences' Depreciation & Amortization (CF) (Quarter) stood at $132000.0 in 2021, then fell by 16.67% to $110000.0 in 2022, then skyrocketed by 44.55% to $159000.0 in 2023, then increased by 10.69% to $176000.0 in 2024, then tumbled by 40.34% to $105000.0 in 2025.
  • Its last three reported values are $105000.0 in Q3 2025, $125000.0 for Q2 2025, and $149000.0 during Q1 2025.